ストックスクリーナーアプリを入手
10.01
6.15%
0.58
アフターアワーズ：
10.01
前日終値:
$9.43
開ける：
$9.41
24時間の取引高:
1.04M
Relative Volume:
1.21
時価総額：
$540.55M
収益：
-
当期純損益:
$-86.60M
株価収益率:
-3.5341
EPS:
-2.8324
ネットキャッシュフロー:
$-67.37M
1週間 パフォーマンス:
+8.45%
1か月 パフォーマンス:
+50.75%
6か月 パフォーマンス:
+154.71%
1年 パフォーマンス:
+26.71%
1日の値動き範囲:
$9.30
$10.09
1週間の範囲:
$9.11
$10.38
52週間の値動き範囲:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
名前
Lexeo Therapeutics Inc
セクター
電話
(212) 547-9879
住所
345 PARK AVENUE SOUTH, NEW YORK
LXEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
10.01 | 678.68M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-15 | 開始されました | Guggenheim | Buy |
| 2025-07-31 | 開始されました | Oppenheimer | Outperform |
| 2024-06-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-06-06 | 開始されました | H.C. Wainwright | Buy |
| 2023-11-28 | 開始されました | Chardan Capital Markets | Buy |
| 2023-11-28 | 開始されました | JP Morgan | Overweight |
| 2023-11-28 | 開始されました | Leerink Partners | Outperform |
| 2023-11-28 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-11-28 | 開始されました | Stifel | Buy |
すべてを表示
Lexeo Therapeutics Inc (LXEO) 最新ニュース
Using Python tools to backtest Lexeo Therapeutics Inc. strategies2025 Investor Takeaways & Real-Time Chart Breakout Alerts - newser.com
Will Lexeo Therapeutics Inc. price bounce be sustainableEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Long term hold vs stop loss in Lexeo Therapeutics Inc.Market Activity Report & Real-Time Stock Price Movement Reports - newser.com
Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com
How Lexeo Therapeutics Inc. stock reacts to bond yieldsMarket Weekly Review & Expert Curated Trade Ideas - newser.com
Will Lexeo Therapeutics Inc. stock outperform Nasdaq index2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Can Lexeo Therapeutics Inc. stock withstand economic slowdownJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Should you hold or exit Lexeo Therapeutics Inc. nowWeekly Volume Report & Risk Managed Investment Strategies - newser.com
Using data filters to optimize entry into Lexeo Therapeutics Inc.2025 Short Interest & Fast Gaining Stock Reports - newser.com
What to do if you’re stuck in Lexeo Therapeutics Inc.2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
Why hedge funds are buying Lexeo Therapeutics Inc. stockQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Best data tools to analyze Lexeo Therapeutics Inc. stockGap Down & Weekly Return Optimization Plans - newser.com
Real time pattern detection on Lexeo Therapeutics Inc. stock2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can Lexeo Therapeutics Inc. stock double in next 5 yearsJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo Therapeutics Inc - GuruFocus
Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteria2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
Risk vs reward if holding onto Lexeo Therapeutics Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - Nasdaq
Market Recap: Can Lexeo Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Fundação Cultural do Pará
Multi asset correlation models including Lexeo Therapeutics Inc.Market Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Lexeo Therapeutics Inc (LXEO) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):